Clinical Trial · NCT05814835

First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant

Overview

This is the first-in-human study of 68Ga/64Cu-FAPI-XT117, which is an prospective, single-arm phase I clinical study.

Sponsor

Chinese PLA General Hospital

Phase

Phase 1

Contacts

Zhihui Shen

shenzhihui301@126.com

010-66936793

ClinicalTrials.gov

NCT05814835